Abstract:Objective: Substantial evidence suggests that high glucose causes endothelial dysfunction, while the potential mechanism is still unknown. In this study, we investigated the effect of high glucose on endothelial mesenchymal transition (EndMT) in human aortic endothelial cells (HAEC). Methods: HAEC were treated with normal glucose (NG; 5 mmol/L) and high glucose (HG; 15 mmol/L or 30 mmol/L d-glucose) for 48 h. Immunofluorescence staining was performed to detect the coexpression of CD31 and markers of myofibroblasts such as fibroblast specific protein1 (FSP1). Expression of FSP1 and α-SMA were detected by RT-PCR and western blot. Results: Treatment of HAEC to high glucose led to a significant increasing expression of FSP1 protein in dose and time dependent manner. Incubation of HAEC with high glucose resulted in a fibroblast-like phenotype. Double staining of HAEC with CD31 revealed approximately 22.7% of FSP1 positive cells in the high glucose group. Interestingly, the angiotensin II type 1 receptor antagonist, irbesartan, significantly attenuated the expression of EndMT (P<0.05). Compared with the NG control, the expression of FSP1, α-SMA and its mRNA in the HG group significantly increased (P<0.01), which were decreased by irbesartan (P<0.05). Conclusion: This study indicated a novel mechanism of EndMT as high glucose induced endothelial damage, which might be mediated by angiotensin II.

High glucose induced endothelial cell develop endothelial mesenchymal transition